UniProt ID | FHOD1_HUMAN | |
---|---|---|
UniProt AC | Q9Y613 | |
Protein Name | FH1/FH2 domain-containing protein 1 | |
Gene Name | FHOD1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1164 | |
Subcellular Localization | Cytoplasm. Cytoplasm, cytoskeleton. Cell projection, bleb. Predominantly cytoplasmic. | |
Protein Description | Required for the assembly of F-actin structures, such as stress fibers. Depends on the Rho-ROCK cascade for its activity. Contributes to the coordination of microtubules with actin fibers and plays a role in cell elongation. Acts synergistically with ROCK1 to promote SRC-dependent non-apoptotic plasma membrane blebbing.. | |
Protein Sequence | MAGGEDRGDGEPVSVVTVRVQYLEDTDPFACANFPEPRRAPTCSLDGALPLGAQIPAVHRLLGAPLKLEDCALQVSPSGYYLDTELSLEEQREMLEGFYEEISKGRKPTLILRTQLSVRVNAILEKLYSSSGPELRRSLFSLKQIFQEDKDLVPEFVHSEGLSCLIRVGAAADHNYQSYILRALGQLMLFVDGMLGVVAHSDTIQWLYTLCASLSRLVVKTALKLLLVFVEYSENNAPLFIRAVNSVASTTGAPPWANLVSILEEKNGADPELLVYTVTLINKTLAALPDQDSFYDVTDALEQQGMEALVQRHLGTAGTDVDLRTQLVLYENALKLEDGDIEEAPGAGGRRERRKPSSEEGKRSRRSLEGGGCPARAPEPGPTGPASPVGPTSSTGPALLTGPASSPVGPPSGLQASVNLFPTISVAPSADTSSERSIYKARFLENVAAAETEKQVALAQGRAETLAGAMPNEAGGHPDARQLWDSPETAPAARTPQSPAPCVLLRAQRSLAPEPKEPLIPASPKAEPIWELPTRAPRLSIGDLDFSDLGEDEDQDMLNVESVEAGKDIPAPSPPLPLLSGVPPPPPLPPPPPIKGPFPPPPPLPLAAPLPHSVPDSSALPTKRKTVKLFWRELKLAGGHGVSASRFGPCATLWASLDPVSVDTARLEHLFESRAKEVLPSKKAGEGRRTMTTVLDPKRSNAINIGLTTLPPVHVIKAALLNFDEFAVSKDGIEKLLTMMPTEEERQKIEEAQLANPDIPLGPAENFLMTLASIGGLAARLQLWAFKLDYDSMEREIAEPLFDLKVGMEQLVQNATFRCILATLLAVGNFLNGSQSSGFELSYLEKVSEVKDTVRRQSLLHHLCSLVLQTRPESSDLYSEIPALTRCAKVDFEQLTENLGQLERRSRAAEESLRSLAKHELAPALRARLTHFLDQCARRVAMLRIVHRRVCNRFHAFLLYLGYTPQAAREVRIMQFCHTLREFALEYRTCRERVLQQQQKQATYRERNKTRGRMITETEKFSGVAGEAPSNPSVPVAVSSGPGRGDADSHASMKSLLTSRPEDTTHNRRSRGMVQSSSPIMPTVGPSTASPEEPPGSSLPSDTSDEIMDLLVQSVTKSSPRALAARERKRSRGNRKSLRRTLKSGLGDDLVQALGLSKGPGLEV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
31 | Glutathionylation | EDTDPFACANFPEPR CCCCCCCCCCCCCCC | 3.04 | 22555962 | |
99 | Phosphorylation | REMLEGFYEEISKGR HHHHHHHHHHHHCCC | 24.41 | - | |
107 | Malonylation | EEISKGRKPTLILRT HHHHCCCCCEEEEEE | 51.53 | 26320211 | |
126 | Ubiquitination | RVNAILEKLYSSSGP HHHHHHHHHHHCCCH | 49.64 | - | |
141 | Phosphorylation | ELRRSLFSLKQIFQE HHHHHHHHHHHHHHH | 39.69 | 24719451 | |
176 | Phosphorylation | GAAADHNYQSYILRA CCCCCCCHHHHHHHH | 8.73 | - | |
213 | Phosphorylation | WLYTLCASLSRLVVK HHHHHHHHHHHHHHH | 26.36 | 27174698 | |
215 | Phosphorylation | YTLCASLSRLVVKTA HHHHHHHHHHHHHHH | 22.52 | 27174698 | |
250 | Phosphorylation | AVNSVASTTGAPPWA HHHHHHHCCCCCCCH | 21.36 | 30576142 | |
251 | Phosphorylation | VNSVASTTGAPPWAN HHHHHHCCCCCCCHH | 28.93 | 30576142 | |
261 | Phosphorylation | PPWANLVSILEEKNG CCCHHHHHHHHHHCC | 25.31 | 30576142 | |
335 | Ubiquitination | VLYENALKLEDGDIE HHHCCCEECCCCCCC | 47.63 | - | |
357 | Phosphorylation | RRERRKPSSEEGKRS CCCCCCCCCHHHHHH | 54.11 | 30576142 | |
358 | Phosphorylation | RERRKPSSEEGKRSR CCCCCCCCHHHHHHH | 48.47 | 26699800 | |
364 | Phosphorylation | SSEEGKRSRRSLEGG CCHHHHHHHHHHCCC | 35.22 | 23403867 | |
367 | Phosphorylation | EGKRSRRSLEGGGCP HHHHHHHHHCCCCCC | 29.66 | 29255136 | |
387 | Phosphorylation | PGPTGPASPVGPTSS CCCCCCCCCCCCCCC | 24.21 | 28348404 | |
401 | Phosphorylation | STGPALLTGPASSPV CCCCCCCCCCCCCCC | 41.80 | 28348404 | |
405 | Phosphorylation | ALLTGPASSPVGPPS CCCCCCCCCCCCCCC | 38.00 | 27251275 | |
406 | Phosphorylation | LLTGPASSPVGPPSG CCCCCCCCCCCCCCC | 26.22 | 27251275 | |
439 | Phosphorylation | TSSERSIYKARFLEN CCCCHHHHHHHHHHH | 10.39 | - | |
465 | Phosphorylation | LAQGRAETLAGAMPN HHHCCHHHHHHCCCC | 22.41 | 22964224 | |
470 | Sulfoxidation | AETLAGAMPNEAGGH HHHHHHCCCCCCCCC | 3.42 | 21406390 | |
486 | Phosphorylation | DARQLWDSPETAPAA CHHHHCCCCCCCCCC | 17.04 | 30266825 | |
489 | Phosphorylation | QLWDSPETAPAARTP HHCCCCCCCCCCCCC | 41.13 | 30266825 | |
495 | Phosphorylation | ETAPAARTPQSPAPC CCCCCCCCCCCCCCH | 22.43 | 30266825 | |
498 | Phosphorylation | PAARTPQSPAPCVLL CCCCCCCCCCCHHHH | 25.00 | 25159151 | |
510 | Phosphorylation | VLLRAQRSLAPEPKE HHHHCHHHCCCCCCC | 19.46 | 23403867 | |
523 | Phosphorylation | KEPLIPASPKAEPIW CCCCCCCCCCCCCCC | 22.91 | 29255136 | |
525 | Ubiquitination | PLIPASPKAEPIWEL CCCCCCCCCCCCCCC | 63.99 | - | |
534 | O-linked_Glycosylation | EPIWELPTRAPRLSI CCCCCCCCCCCCCEE | 52.68 | OGP | |
534 | Phosphorylation | EPIWELPTRAPRLSI CCCCCCCCCCCCCEE | 52.68 | 23403867 | |
540 | Phosphorylation | PTRAPRLSIGDLDFS CCCCCCCEECCCCHH | 26.29 | 27732954 | |
547 | Phosphorylation | SIGDLDFSDLGEDED EECCCCHHHCCCCCC | 31.43 | 28270605 | |
573 | Phosphorylation | GKDIPAPSPPLPLLS CCCCCCCCCCCCCCC | 41.05 | 29255136 | |
580 | Phosphorylation | SPPLPLLSGVPPPPP CCCCCCCCCCCCCCC | 45.48 | 29255136 | |
635 | Methylation | KLFWRELKLAGGHGV HHHHHHHHHHCCCCC | 31.38 | - | |
676 | Ubiquitination | HLFESRAKEVLPSKK HHHHHHHHHHCCCCC | 47.44 | - | |
681 | Phosphorylation | RAKEVLPSKKAGEGR HHHHHCCCCCCCCCC | 42.50 | 24719451 | |
690 | Phosphorylation | KAGEGRRTMTTVLDP CCCCCCCCEEEECCC | 19.94 | 25159151 | |
692 | Phosphorylation | GEGRRTMTTVLDPKR CCCCCCEEEECCCCC | 17.09 | 22199227 | |
693 | Phosphorylation | EGRRTMTTVLDPKRS CCCCCEEEECCCCCC | 14.30 | 28060719 | |
700 | Phosphorylation | TVLDPKRSNAINIGL EECCCCCCCCEEECC | 36.42 | 22817900 | |
708 | Phosphorylation | NAINIGLTTLPPVHV CCEEECCCCCCHHHH | 22.52 | 22817900 | |
730 | Ubiquitination | FDEFAVSKDGIEKLL CHHHCCCHHHHHHHH | 54.07 | - | |
738 | Phosphorylation | DGIEKLLTMMPTEEE HHHHHHHHCCCCHHH | 23.12 | 30206219 | |
742 | Phosphorylation | KLLTMMPTEEERQKI HHHHCCCCHHHHHHH | 37.83 | 30206219 | |
816 | Phosphorylation | EQLVQNATFRCILAT HHHHHHHHHHHHHHH | 21.11 | - | |
823 | Phosphorylation | TFRCILATLLAVGNF HHHHHHHHHHHHHHH | 20.89 | 18452278 | |
851 | Ubiquitination | LEKVSEVKDTVRRQS HHHHHHHHHHHHHHH | 43.56 | - | |
874 | Phosphorylation | VLQTRPESSDLYSEI HHHHCCCCCCHHHHC | 31.66 | - | |
878 | Phosphorylation | RPESSDLYSEIPALT CCCCCCHHHHCHHHH | 14.84 | - | |
889 | Ubiquitination | PALTRCAKVDFEQLT HHHHHHHCCCHHHHH | 46.06 | - | |
912 | Phosphorylation | RSRAAEESLRSLAKH HHHHHHHHHHHHHHH | 22.16 | 22985185 | |
915 | Phosphorylation | AAEESLRSLAKHELA HHHHHHHHHHHHCHH | 37.66 | 22985185 | |
918 | Ubiquitination | ESLRSLAKHELAPAL HHHHHHHHHCHHHHH | 42.79 | - | |
960 | Phosphorylation | RFHAFLLYLGYTPQA HHHHHHHHCCCCHHH | 10.54 | - | |
963 | Phosphorylation | AFLLYLGYTPQAARE HHHHHCCCCHHHHHH | 16.80 | - | |
1000 | Ubiquitination | RVLQQQQKQATYRER HHHHHHHHHHHHHHH | 37.25 | - | |
1010 | Phosphorylation | TYRERNKTRGRMITE HHHHHHHHHCCCCCC | 41.74 | 29514088 | |
1016 | Phosphorylation | KTRGRMITETEKFSG HHHCCCCCCCCCCCC | 27.75 | 29514088 | |
1018 | Phosphorylation | RGRMITETEKFSGVA HCCCCCCCCCCCCCC | 35.51 | 29514088 | |
1039 | Phosphorylation | PSVPVAVSSGPGRGD CCCCEEEECCCCCCC | 21.60 | 22210691 | |
1040 | Phosphorylation | SVPVAVSSGPGRGDA CCCEEEECCCCCCCC | 42.27 | 22210691 | |
1044 | Methylation | AVSSGPGRGDADSHA EEECCCCCCCCCCHH | 42.84 | - | |
1052 | Phosphorylation | GDADSHASMKSLLTS CCCCCHHHHHHHHHC | 22.71 | 27535140 | |
1055 | Phosphorylation | DSHASMKSLLTSRPE CCHHHHHHHHHCCCC | 21.70 | 28555341 | |
1058 | Phosphorylation | ASMKSLLTSRPEDTT HHHHHHHHCCCCCCC | 28.16 | 24719451 | |
1076 | Phosphorylation | RSRGMVQSSSPIMPT CCCCCCCCCCCCCCC | 22.75 | 30624053 | |
1077 | Phosphorylation | SRGMVQSSSPIMPTV CCCCCCCCCCCCCCC | 24.04 | 30624053 | |
1078 | Phosphorylation | RGMVQSSSPIMPTVG CCCCCCCCCCCCCCC | 24.56 | 30624053 | |
1083 | Phosphorylation | SSSPIMPTVGPSTAS CCCCCCCCCCCCCCC | 22.25 | 30624053 | |
1087 | Phosphorylation | IMPTVGPSTASPEEP CCCCCCCCCCCCCCC | 30.58 | 30624053 | |
1088 | Phosphorylation | MPTVGPSTASPEEPP CCCCCCCCCCCCCCC | 34.00 | 30624053 | |
1090 | Phosphorylation | TVGPSTASPEEPPGS CCCCCCCCCCCCCCC | 32.69 | 30624053 | |
1097 | Phosphorylation | SPEEPPGSSLPSDTS CCCCCCCCCCCCCCH | 34.18 | 30624053 | |
1098 | Phosphorylation | PEEPPGSSLPSDTSD CCCCCCCCCCCCCHH | 50.65 | 30624053 | |
1101 | Phosphorylation | PPGSSLPSDTSDEIM CCCCCCCCCCHHHHH | 59.83 | 30624053 | |
1103 | Phosphorylation | GSSLPSDTSDEIMDL CCCCCCCCHHHHHHH | 42.27 | 30624053 | |
1104 | Phosphorylation | SSLPSDTSDEIMDLL CCCCCCCHHHHHHHH | 37.93 | 30624053 | |
1114 | Phosphorylation | IMDLLVQSVTKSSPR HHHHHHHHHHCCCHH | 25.03 | 26074081 | |
1116 | Phosphorylation | DLLVQSVTKSSPRAL HHHHHHHHCCCHHHH | 30.38 | 26074081 | |
1118 | Phosphorylation | LVQSVTKSSPRALAA HHHHHHCCCHHHHHH | 35.89 | 26074081 | |
1119 | Phosphorylation | VQSVTKSSPRALAAR HHHHHCCCHHHHHHH | 21.69 | 26074081 | |
1131 | Phosphorylation | AARERKRSRGNRKSL HHHHHHHHHCCHHHH | 47.80 | 18239683 | |
1137 | Phosphorylation | RSRGNRKSLRRTLKS HHHCCHHHHHHHHHH | 24.70 | 18239683 | |
1141 | Phosphorylation | NRKSLRRTLKSGLGD CHHHHHHHHHHCCCH | 31.91 | 28450419 | |
1144 | Phosphorylation | SLRRTLKSGLGDDLV HHHHHHHHCCCHHHH | 42.22 | 28450419 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
99 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
498 | S | Phosphorylation | Kinase | ERK2 | P28482 | PSP |
498 | S | Phosphorylation | Kinase | ERK1 | P27361 | PSP |
1131 | S | Phosphorylation | Kinase | PRKG1 | Q13976 | GPS |
1131 | S | Phosphorylation | Kinase | ROCK1 | Q13464 | PSP |
1137 | S | Phosphorylation | Kinase | ROCK1 | Q13464 | PSP |
1141 | T | Phosphorylation | Kinase | ROCK1 | Q13464 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FHOD1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FHOD1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ACTG_HUMAN | ACTG1 | physical | 14576350 | |
FHOD1_HUMAN | FHOD1 | physical | 14576350 | |
FHOD1_HUMAN | FHOD1 | physical | 11590143 | |
GALE_HUMAN | GALE | physical | 26344197 | |
SYTC_HUMAN | TARS | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-498 AND SER-523, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367; THR-495; SER-498;SER-523 AND THR-690, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367; SER-486; THR-495;SER-498; SER-523 AND SER-573, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-498, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-495; SER-498 ANDSER-523, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367, AND MASSSPECTROMETRY. |